Our results confirmed the clinical relevance of PSMD14-mediated regulation of CARM1 in HCC, suggesting that the upregulation of CARM1 and PSMD14 may hold promise as prognostic indicators for patients with HCC. This evidence concerns the gene PSMD14 and hepatocellular carcinoma.